Case reports: Four concomitant non-fatal intoxications with AB-FUBINACA and MDMA

European Monitoring Centre for Drugs and Drug Addiction, 2016 Debruyne, 2015, Emerging drugs of abuse: current perspectives on synthetic cannabinoids, Subst Abuse Rehabil, 6, 113, 10.2147/SAR.S73586 Alvarez, 2015, Cannabinoïdes de synthèse : aspects pharmacologiques, Toxicol Anal Clin, 27, 23 Beck, 2015, Les niveaux d’usage des drogues illicites en France en 2014, Tendances OFDT, 99, 1 Beck, 2015 Pélissier-Alicot, 2015, Les cannabinoïdes de synthèse : épidémiologie, modalités de consommations et effets cliniques, Toxicol Anal Clin, 27, 33 Mazoyer, 2015, Cannabinoïdes de synthèse : méthodes analytiques, Toxicol Anal Clin, 27, 184 Namera, 2015, Comprehensive review of the detection methods for synthetic cannabinoids and cathinones, Forensic Toxicol, 33, 175, 10.1007/s11419-015-0270-0 Adams, 2016, “Zombie” outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York, N Engl J Med Meyer, 2016, Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices – where do we stand today?, Anal Chim Acta, 927, 13, 10.1016/j.aca.2016.04.046 Castaneto, 2015, Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices, Drug Metab Rev, 47, 124, 10.3109/03602532.2015.1029635 Buchler, 2009 Uchiyama, 2013, Forensic Toxicol, 31, 93, 10.1007/s11419-012-0171-4 Allibe-Signorini, 2008, Improvement of toxicologic GC-MS screening using a deconvolution software (AMDIS) and SIM/SCAN mode, Ann Toxicol Anal, 20, 57, 10.1051/ata/2009001 Scientific Working Group for the Analysis of seizure Drugs (SWGDRUG). 2015. [Available from: http://www.swgdrug.org (downloaded 01/15/2016)]. Lacroix, 2008, Simultaneous determination of opiates, cocainics and amphetamines by on-line solid phase extraction coupled with liquid chromatography/tandem mass spectrometry, Ann Toxicol Anal, 20, 25, 10.1051/ata:2008004 Reynaud, 2016, Décès toxique à l’amlodipine et l’olmésartan : à propos d’un cas avec pharmacobézoard, Toxicol Anal Clin, 28, 286 Kronstrand, 2014, LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine, Anal Bioanal Chem, 406, 3599, 10.1007/s00216-013-7574-x Boumrah, 2016, In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high-resolution MS, Drug Test Anal, 8, 248, 10.1002/dta.1865 Kintz, 2016, Detection of the designer benzodiazepine metizolam, in urine and preliminary data on its metabolism, Drug Test Anal, 10.1002/dta.2099 Musshoff, 2004, Fatal blood and tissue concentrations of more than 200 drugs, Forensic Sci Int, 142, 161, 10.1016/j.forsciint.2004.02.017 Ghysel-Laporte, 2012, Amphétamines et dérivés, 455 Cooper, 2016, Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal, Curr Psychiatry Rep, 18, 52, 10.1007/s11920-016-0694-1 Castaneto, 2014, Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications, Drug Alcohol Depend, 144, 12, 10.1016/j.drugalcdep.2014.08.005 Klavz, 2016, Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC, Forensic Sci Int, 265, 121, 10.1016/j.forsciint.2016.01.018 Roussel, 2016, The development of new psychoactive substances in France, Toxicol Anal Clin Ladroue, 2016, Les NPS en vogue en région Rhône-Alpes : rapport de cas, Toxicol Anal Clin Vaiano, 2016, A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases, J Pharm Biomed Anal, 129, 441, 10.1016/j.jpba.2016.07.009 Vikingsson, 2016, Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry, Drug Test Anal, 8, 950, 10.1002/dta.1896 Takayama, 2014, UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome, Biomed Chromatogr, 28, 831, 10.1002/bmc.3155 Castaneto, 2015, Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry, Forensic Toxicol, 33, 295, 10.1007/s11419-015-0275-8 Gaulier, 2015, Nouvelles substances psychoactives : approches analytiques